Copyright
©The Author(s) 2023.
World J Clin Oncol. Nov 24, 2023; 14(11): 479-503
Published online Nov 24, 2023. doi: 10.5306/wjco.v14.i11.479
Published online Nov 24, 2023. doi: 10.5306/wjco.v14.i11.479
Figure 3 Survival analysis of COP9 signalosome subunit 6.
A: Overall survival (OS) and disease-free survival analysis conducted with the GEPIA2 website using the log-rank test (P < 0.05); B: Forest plots illustrating disease-specific survival (DSS), OS, progression-free interval (PFI), and disease-free interval (DFI) analyzed with Cox analysis in R software. ACC: Adrenocortical carcinoma; GBM: Glioblastoma multiforme; KICH: Kidney chromophobe; KIRP: Kidney renal papillary cell carcinoma; LGG: Lower grade glioma; LIHC: Liver hepatocellular carcinoma; LUAD: Lung adenocarcinoma; MESO: Mesothelioma; STAD: Stomach adenocarcinoma.
- Citation: Wang SL, Zhuo GZ, Wang LP, Jiang XH, Liu GH, Pan YB, Li YR. Computational exploration of the significance of COPS6 in cancer: Functional and clinical relevance across tumor types. World J Clin Oncol 2023; 14(11): 479-503
- URL: https://www.wjgnet.com/2218-4333/full/v14/i11/479.htm
- DOI: https://dx.doi.org/10.5306/wjco.v14.i11.479